Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published ...

Severe abdominal pain was one of the first signs of pancreatic cancer for Paula Rowland. She ignored it for months. After ...

Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

According to Johns Hopkins Pathology, pancreatic cancer is the third leading cause of cancer death in the United States. It's more common in African Americans and is often diagnosed in advanced ...

Discover why pancreatic cancer's warning signs often go unnoticed, masquerading as everyday health issues, learn the crucial red flags that shouldn't be ignored ...

A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.

Gemcitabine is a pyrimidine analog that was established as the standard of care for treatment with metastatic and/or locally advanced pancreatic cancer. Erlotinib (EGF receptor tyrosine kinase ...

Toward Improved Early Detection of Pancreatic Cancer Feb. 18 ... Cells on Track -- New Perspectives for the Treatment of Liver Cancer Feb. 13, 2025 — A guardian molecule ensures that liver ...

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...

Objective Pancreatic ductal adenocarcinoma (PDAC) shows a remarkable predilection for liver metastasis. Pro-oncogenic secretome delivery and trafficking via exosomes are crucial for pre-metastatic ...